These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23350892)

  • 1. Pleurocidin-family cationic antimicrobial peptides mediate lysis of multiple myeloma cells and impair the growth of multiple myeloma xenografts.
    Hilchie AL; Conrad DM; Coombs MR; Zemlak T; Doucette CD; Liwski RS; Hoskin DW
    Leuk Lymphoma; 2013 Oct; 54(10):2255-62. PubMed ID: 23350892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts.
    Hilchie AL; Doucette CD; Pinto DM; Patrzykat A; Douglas S; Hoskin DW
    Breast Cancer Res; 2011 Oct; 13(5):R102. PubMed ID: 22023734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced killing of breast cancer cells by a d-amino acid analog of the winter flounder-derived pleurocidin NRC-03.
    Hilchie AL; Haney EF; Pinto DM; Hancock RE; Hoskin DW
    Exp Mol Pathol; 2015 Dec; 99(3):426-34. PubMed ID: 26344617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Acute Phase Protein Hepcidin Is Cytotoxic to Human and Mouse Myeloma Cells.
    Conrad DM; Hilchie AL; McMillan KAM; Liwski RS; Hoskin DW; Power Coombs MR
    Anticancer Res; 2021 Feb; 41(2):601-608. PubMed ID: 33517264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin.
    Dalva-Aydemir S; Bajpai R; Martinez M; Adekola KU; Kandela I; Wei C; Singhal S; Koblinski JE; Raje NS; Rosen ST; Shanmugam M
    Clin Cancer Res; 2015 Mar; 21(5):1161-71. PubMed ID: 25542900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Signaling Model Connects Vorinostat Pharmacokinetics and Tumor Growth Response in Multiple Myeloma Xenografts.
    Nanavati C; Ruszaj D; Mager DE
    CPT Pharmacometrics Syst Pharmacol; 2017 Nov; 6(11):756-764. PubMed ID: 29045072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care.
    Paíno T; Garcia-Gomez A; González-Méndez L; San-Segundo L; Hernández-García S; López-Iglesias AA; Algarín EM; Martín-Sánchez M; Corbacho D; Ortiz-de-Solorzano C; Corchete LA; Gutiérrez NC; Maetos MV; Garayoa M; Ocio EM
    Clin Cancer Res; 2017 Jan; 23(1):225-238. PubMed ID: 27440267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of rosiglitazone and all-trans-retinoic acid on angiogenesis and growth of myeloma xenograft in nude mice].
    Huang HW; Chen P; Li BZ; Fu JX; Li J; Zhang XH; Liu R; Fan YY; Zhang H; Chow HC; Leung AY; Liang R
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):652-7. PubMed ID: 23159076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in
    Díaz T; Rodríguez V; Lozano E; Mena MP; Calderón M; Rosiñol L; Martínez A; Tovar N; Pérez-Galán P; Bladé J; Roué G; de Larrea CF
    Haematologica; 2017 Oct; 102(10):1776-1784. PubMed ID: 28751557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents.
    Morash MG; Douglas SE; Robotham A; Ridley CM; Gallant JW; Soanes KH
    Dis Model Mech; 2011 Sep; 4(5):622-33. PubMed ID: 21729875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin inhibits proliferation and induces apoptosis of multiple myeloma cells through regulation of Bcl-2 and Bax and suppression of VEGF.
    Ding JH; Yuan LY; Huang RB; Chen GA
    Eur J Haematol; 2014 Oct; 93(4):329-39. PubMed ID: 24766194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial peptide pleurocidin synergizes with antibiotics through hydroxyl radical formation and membrane damage, and exerts antibiofilm activity.
    Choi H; Lee DG
    Biochim Biophys Acta; 2012 Dec; 1820(12):1831-8. PubMed ID: 22921812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts.
    Zhang M; Wei W; Sun Y; Jiang X; Ying X; Tao R; Ni L
    Arch Oral Biol; 2016 Oct; 70():79-87. PubMed ID: 27341459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
    Park J; Park E; Jung CK; Kang SW; Kim BG; Jung Y; Kim TH; Lim JY; Lee SE; Min CK; Won KA
    BMC Cancer; 2016 Mar; 16():247. PubMed ID: 27012957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antidepressant amitriptyline shows potent therapeutic activity against multiple myeloma.
    Zhang Z; Du X; Zhao C; Cao B; Zhao Y; Mao X
    Anticancer Drugs; 2013 Sep; 24(8):792-8. PubMed ID: 23708819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a proapoptotic peptide towards cancer cells.
    Jäkel CE; Meschenmoser K; Kim Y; Weiher H; Schmidt-Wolf IG
    In Vivo; 2012; 26(3):419-26. PubMed ID: 22523294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantiomeric CopA3 dimer peptide suppresses cell viability and tumor xenograft growth of human gastric cancer cells.
    Lee JH; Kim IW; Shin YP; Park HJ; Lee YS; Lee IH; Kim MA; Yun EY; Nam SH; Ahn MY; Kang D; Hwang JS
    Tumour Biol; 2016 Mar; 37(3):3237-45. PubMed ID: 26432335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma.
    Munugalavadla V; Mariathasan S; Slaga D; Du C; Berry L; Del Rosario G; Yan Y; Boe M; Sun L; Friedman LS; Chesi M; Leif Bergsagel P; Ebens A
    Oncogene; 2014 Jan; 33(3):316-25. PubMed ID: 23318440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fish antimicrobial peptide, tilapia hepcidin TH2-3, shows potent antitumor activity against human fibrosarcoma cells.
    Chen JY; Lin WJ; Lin TL
    Peptides; 2009 Sep; 30(9):1636-42. PubMed ID: 19539000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies.
    Deckert J; Wetzel MC; Bartle LM; Skaletskaya A; Goldmacher VS; Vallée F; Zhou-Liu Q; Ferrari P; Pouzieux S; Lahoute C; Dumontet C; Plesa A; Chiron M; Lejeune P; Chittenden T; Park PU; Blanc V
    Clin Cancer Res; 2014 Sep; 20(17):4574-83. PubMed ID: 24987056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.